Alps Group Inc
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q3 | -0.24 | $0 | -$250,259 |
| 2025 Q2 | -0.24 | $0 | -$250,259 |
| 2025 Q2 | -0.24 | $0 | -$270,410 |
| 2025 Q1 | -0.24 | $0 | -$270,410 |
| 2025 Q4 | -0.20 | $0 | -$160,040 |
| 2025 Q1 | -0.20 | $0 | -$160,040 |
| 2024 Q4 |
| -0.05 |
| $0 |
| -$281,710 |
| 2024 Q3 | -0.05 | $0 | -$281,710 |